Ni Xie

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Metastatic Breast Cancer

Neoadjuvant Chemotherapy

Top Venues

Analytical chemistry

Breast cancer (Dove Medical Press)

International journal of nanomedicine

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Huihui Yang, Dong Chen, Yanfei Zhang, Peixiu Yuan, Ni Xie, Zong Dai
MiRNA and mRNA-Controlled Double-Cascaded Amplifying Circuit Nanosensor for Accurate Discrimination of Breast Cancers in Living Cells, Animals, and Organoids. Analytical chemistry 96 (10) (2024)
Huihui Yang, Dong Chen, Yanfei Zhang, Peixiu Yuan, Ni Xie, Zong Dai
MiRNA and mRNA-Controlled Double-Cascaded Amplifying Circuit Nanosensor for Accurate Discrimination of Breast Cancers in Living Cells, Animals, and Organoids. Analytical chemistry 96 (10) (2024)
Yujie Wang, Tingting Deng, Xi Liu, Xueyang Fang, Yongpan Mo, Ni Xie, Guohui Nie, Bin Zhang, Xiaoqin Fan
Smart Nanoplatforms Responding to the Tumor Microenvironment for Precise Drug Delivery in Cancer Therapy. International journal of nanomedicine 19 (2024)
Huihui Yang, Dong Chen, Yanfei Zhang, Peixiu Yuan, Ni Xie, Zong Dai
MiRNA and mRNA-Controlled Double-Cascaded Amplifying Circuit Nanosensor for Accurate Discrimination of Breast Cancers in Living Cells, Animals, and Organoids. Analytical chemistry 96 (10) (2024)
Lvwen Ning, Ni Xie
SIRT3 Expression Predicts Overall Survival and Neoadjuvant Chemosensitivity in Triple-Negative Breast Cancer. Cancer management and research 16 (2024)
Huihui Yang, Dong Chen, Yanfei Zhang, Peixiu Yuan, Ni Xie, Zong Dai
MiRNA and mRNA-Controlled Double-Cascaded Amplifying Circuit Nanosensor for Accurate Discrimination of Breast Cancers in Living Cells, Animals, and Organoids. Analytical chemistry (2024)
Yujie Wang, Tingting Deng, Xi Liu, Xueyang Fang, Yongpan Mo, Ni Xie, Guohui Nie, Bin Zhang, Xiaoqin Fan
Smart Nanoplatforms Responding to the Tumor Microenvironment for Precise Drug Delivery in Cancer Therapy. International journal of nanomedicine 19 (2024)
Lvwen Ning, Ni Xie
SIRT3 Expression Predicts Overall Survival and Neoadjuvant Chemosensitivity in Triple-Negative Breast Cancer. Cancer management and research 16 (2024)
Qin Huo, Lvwen Ning, Ni Xie
Identification of GZMA as a Potential Therapeutic Target Involved in Immune Infiltration in Breast Cancer by Integrated Bioinformatical Analysis. Breast cancer (Dove Medical Press) 15 (2023)
Qin Huo, Lvwen Ning, Ni Xie
Identification of GZMA as a Potential Therapeutic Target Involved in Immune Infiltration in Breast Cancer by Integrated Bioinformatical Analysis. Breast cancer (Dove Medical Press) 15 (2023)
Yi-Zi Zheng, Jia-Ying Li, Lv-Wen Ning, Ni Xie
Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy. Breast cancer (Dove Medical Press) 14 (2022)
Yi-Zi Zheng, Jia-Ying Li, Lv-Wen Ning, Ni Xie
Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy. Breast cancer (Dove Medical Press) 14 (2022)
Qin Huo, Zhenwei Li, Siqi Chen, Juan Wang, Jiaying Li, Ni Xie
VWCE as a potential biomarker associated with immune infiltrates in breast cancer. Cancer cell international 21 (1) (2021)
Jialang Zhuang, Siqi Chen, Ye Hu, Fan Yang, Qin Huo, Ni Xie
Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer. International journal of nanomedicine 16 (2021)
Fan Yang, Ye Hu, Ling Shao, Jialang Zhuang, Qin Huo, Shengnan He, Siqi Chen, Juan Wang, Ni Xie
SIRT7 interacts with TEK (TIE2) to promote adriamycin induced metastasis in breast cancer. Cellular oncology (Dordrecht) 44 (6) (2021)
Qin Huo, Xi He, Zhenwei Li, Fan Yang, Shengnan He, Ling Shao, Ye Hu, Siqi Chen, Ni Xie
SCUBE3 serves as an independent poor prognostic factor in breast cancer. Cancer cell international 21 (1) (2021)